3Q22 results roughly inline. Sales/ net profit grew by 9%/ 34% YoY to RMB 62.9bn/ 3.7bn, inline with BBG est. Relatively soft for Casarte in 3Q22, but long-term growth is still intact.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.